Glenmark Pharma receives ANDA approval for Lacosamide tablets
The company plans to launch the product immediately
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Glenmark Pharma
Glenmark gets nod from US FDA for generic drug
The product is a generic version of Bausch Health US LLC's MetroGel-Vaginal
Glenmark and Lotus enter into partnership for Ryaltris in key South East Asian markets
Glenmark will be responsible for the manufacturing and supply of Ryaltris, while Lotus International will be responsible for the…
Glenmark Pharmaceuticals makes it to DJSI for fourth consecutive year
Glenmark is among 15 companies from India and one of the five companies from the pharmaceuticals, biotechnology and lifesciences…
Glenmark launches Ryaltris-AZ in India
It has been launched at a price of Rs 175/- per pack of 75 metered doses
Glenmark gets marketing approval for Ryaltris, single nasal spray in Russia
It is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis in adults and children over 12 years of age
Glenmark launches SUTIB (Sunitinib) capsules in India to treat kidney cancer
The company informs that the drug is priced 96 per cent lower than the innovator brand and reduces the risk of kidney cancer…
Glenmark gets USFDA approval for Clindamycin Phosphate Gel
It is an antibiotic indicated for the treatment of acne
Glenmark Pharma receives US FDA nod for seizure treatment drug
Glenmark Pharma has received final approval from the US health regulator for Topiramate extended-release capsules, used to treat…
Glenmark Pharma gets USFDA approval for Amphetamine Sulfate Tablets
The tablets are used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy, a sleeping disorder